Maider Urtaran-Laresgoiti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maider Urtaran-Laresgoiti has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Roberto Nuño-Solinís
Deusto Business School Health, University of Deusto, 48014 Bilbao, Spain
4 shared publications Roberto Nuño-Solinís
Affiliation Deusto Business School Health, University of Deusto, Bilbao, Spain
3 shared publications- Elena Urizar
Deusto Business School Health, University of Deusto, 48014 Bilbao, Spain
2 shared publications - Janire Fonseca Peso
Universidad de Deusto
2 shared publications Arturo Álvarez-Rosete
New Health Foundation, Spain
1 shared publicationCarlos Solano
Affiliation Department of Medicine, Hematology Service, Hospital Clínico Universitario-INCLIVA, School of Medicine, University of Valencia, Valencia, Spain
1 shared publication
Latest Publications
- Open Access
- 29 June 2026
- Published by Ciudad y Territorio Estudios Territoriales in Ciudad Y Territorio Estudios Territoriales
- Vol. 58 (228) , 622-645
Incorporando una mirada de salud a los programas de regeneración urbana: Evaluación de Impacto en Salud del programa Opengela en el País Vasco
La evidencia sobre el impacto en salud de los programas de regeneración urbana ha aumentado los últimos años. Sin embargo, la mayoría de estudios se han centrado en visibilizar ese impacto, siendo menos frecuentes aquellos que analizan cómo modificar estas intervenciones para que sean más saludables. Se realizó una Evaluación de Impacto en Salud (EIS) participativa y concurrente de un programa de regeneración urbana en el País Vasco. Se emplearon metodologías mixtas para identificar posibles impactos del programa en la salud. Consecuentemente, se formularon 25 recomendaciones dirigidas a maximizar los efectos positivos y minimizar los negativos del programa sobre la salud. Estas recomendaciones incluyen, por un lado, aquellas a considerarse entre la población residente y las intervenciones desarrolladas en las viviendas intervenidas, y por otro, las orientadas a las intervenciones a nivel de barrio. Entre otras se muestran la necesidad de informar al vecindario para una ventilación adecuada o de incorporar estrategias que puedan aminorar la presión económica derivada de las obras. Estas recomendaciones contribuirían a que la expansión del programa al conjunto del País Vasco tuviera un impacto positivo mayor sobre la salud. Este es un ejemplo de cómo la EIS puede ser una herramienta valiosa en planificación urbana.
- 29 June 2026
- Published by Ciudad y Territorio Estudios Territoriales in Ciudad Y Territorio Estudios Territoriales
- Vol. 58 (228) , 622-645
Open AccessIncorporando una mirada de salud a los programas de regeneración urbana: Evaluación de Impacto en Salud del programa Opengela en el País Vasco
La evidencia sobre el impacto en salud de los programas de regeneración urbana ha aumentado los últimos años. Sin embargo, la mayoría de estudios se han centrado en visibilizar ese impacto, siendo menos frecuentes aquellos que analizan cómo modificar estas intervenciones para que sean más saludables. Se realizó una Evaluación de Impacto en Salud (EIS) participativa y concurrente de un programa de regeneración urbana en el País Vasco. Se emplearon metodologías mixtas para identificar posibles impactos del programa en la salud. Consecuentemente, se formularon 25 recomendaciones dirigidas a maximizar los efectos positivos y minimizar los negativos del programa sobre la salud. Estas recomendaciones incluyen, por un lado, aquellas a considerarse entre la población residente y las intervenciones desarrolladas en las viviendas intervenidas, y por otro, las orientadas a las intervenciones a nivel de barrio. Entre otras se muestran la necesidad de informar al vecindario para una ventilación adecuada o de incorporar estrategias que puedan aminorar la presión económica derivada de las obras. Estas recomendaciones contribuirían a que la expansión del programa al conjunto del País Vasco tuviera un impacto positivo mayor sobre la salud. Este es un ejemplo de cómo la EIS puede ser una herramienta valiosa en planificación urbana.
- Open Access
- 17 January 2022
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 22 (1) , 2
Community Based Participatory Research For The Development of a Compassionate Community: The Case of Getxo Zurekin
In the face of a growing ageing population and rising care needs, compassionate communities seek to visualize the community as an equal partner in the complex task of providing quality social and health care at the end of life. Getxo Zurekin is a social innovation example for the creation of a compassionate community in Getxo, one of the most populated cities in the province of Biscay, with 25.46% of its population aged over 65. Mixed methodologies have been applied, active listening and co-creation of actions and strategies towards improving care and quality of life for people and families facing advanced disease and end of life situations, with more than 80 people interviewed to conform the basis for a collective sense making. The initiative has reached more than 1,000 people in Getxo. Following a systemic approach, horizontal relationships and cross-sectoral collaborations have allowed engaging the active involvement of local agents in the collective sense making and co- creation process. Getxo Zurekin represents an example of a participatory action research model, which has shown to be effective to meet initial targets towards creation of a compassionate community.
- 17 January 2022
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 22 (1) , 2
Open AccessCommunity Based Participatory Research For The Development of a Compassionate Community: The Case of Getxo Zurekin
In the face of a growing ageing population and rising care needs, compassionate communities seek to visualize the community as an equal partner in the complex task of providing quality social and health care at the end of life. Getxo Zurekin is a social innovation example for the creation of a compassionate community in Getxo, one of the most populated cities in the province of Biscay, with 25.46% of its population aged over 65. Mixed methodologies have been applied, active listening and co-creation of actions and strategies towards improving care and quality of life for people and families facing advanced disease and end of life situations, with more than 80 people interviewed to conform the basis for a collective sense making. The initiative has reached more than 1,000 people in Getxo. Following a systemic approach, horizontal relationships and cross-sectoral collaborations have allowed engaging the active involvement of local agents in the collective sense making and co- creation process. Getxo Zurekin represents an example of a participatory action research model, which has shown to be effective to meet initial targets towards creation of a compassionate community.
- 27 December 2021
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 44 (3) , 339-350
The approach to hypercholesterolemia in health strategies and plans in Spain: present situation and future proposals
Fundamento. Las enfermedades cardiovasculares (ECV) son la principal causa de muerte a nivel mundial y la hipercolesterolemia (HC) es un importante factor de riesgo cardiovascular (FRCV). En España, aproximadamente un 25% de los adultos de mediana edad presentan hipercolesterolemia. Nuestro objetivo fue analizar las estrategias y planes de salud existentes en España respecto a las ECV y a la HC, y definir líneas de actuación para su control desde la gestión y política sanitaria. Material y métodos. Estudio observacional, descriptivo. En la primera fase se revisó la literatura y se realizaron seis entrevistas semiestructuradas; en una segunda fase, 12 expertos identificaron las barreras existentes y propusieron estrategias para reducir la mortalidad prematura por las ECV. Resultados. Se identificaron 51 documentos de planificación, el 43% hacían referencia a la HC. Se detectó una alta variabilidad en la implementación de iniciativas a nivel autonómico para el control de la HC. Las barreras identificadas para explicar estos resultados fueron: banalización de la HC, falta de participación activa de agentes clave, desconocimiento del impacto de la HC, el modelo de atención y los circuitos asistenciales existentes, y las políticas sanitarias a corto plazo y con escasa dedicación de recursos a la HC. Conclusiones. A pesar del impacto en salud y socioeconómico de las ECV y de la HC en España, el peso de la HC en las políticas de salud no parece corresponderse con esa relevancia. Faltan medidas para su abordaje, pese a la evidencia de su efectividad. Este estudio propone medidas concretas para avanzar en su control.
- 27 December 2021
- Published by Gobierno de Navarra in Anales del Sistema Sanitario de Navarra
- Vol. 44 (3) , 339-350
The approach to hypercholesterolemia in health strategies and plans in Spain: present situation and future proposals
Fundamento. Las enfermedades cardiovasculares (ECV) son la principal causa de muerte a nivel mundial y la hipercolesterolemia (HC) es un importante factor de riesgo cardiovascular (FRCV). En España, aproximadamente un 25% de los adultos de mediana edad presentan hipercolesterolemia. Nuestro objetivo fue analizar las estrategias y planes de salud existentes en España respecto a las ECV y a la HC, y definir líneas de actuación para su control desde la gestión y política sanitaria. Material y métodos. Estudio observacional, descriptivo. En la primera fase se revisó la literatura y se realizaron seis entrevistas semiestructuradas; en una segunda fase, 12 expertos identificaron las barreras existentes y propusieron estrategias para reducir la mortalidad prematura por las ECV. Resultados. Se identificaron 51 documentos de planificación, el 43% hacían referencia a la HC. Se detectó una alta variabilidad en la implementación de iniciativas a nivel autonómico para el control de la HC. Las barreras identificadas para explicar estos resultados fueron: banalización de la HC, falta de participación activa de agentes clave, desconocimiento del impacto de la HC, el modelo de atención y los circuitos asistenciales existentes, y las políticas sanitarias a corto plazo y con escasa dedicación de recursos a la HC. Conclusiones. A pesar del impacto en salud y socioeconómico de las ECV y de la HC en España, el peso de la HC en las políticas de salud no parece corresponderse con esa relevancia. Faltan medidas para su abordaje, pese a la evidencia de su efectividad. Este estudio propone medidas concretas para avanzar en su control.
- Open Access
- 1 September 2021
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 21 (S1) , 193
Evaluation of value-based integrated care in Spain: results from six Regions
- 1 September 2021
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 21 (S1) , 193
Open AccessEvaluation of value-based integrated care in Spain: results from six Regions
- Open Access
- 12 August 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0254135
Hospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs
The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in-hospital and outpatient models for autologous and allogeneic HSCT using the Triple Aim framework: health outcomes, costs and experience of care. We found evidence on improved health outcomes and quality of life, on enhanced safety and effectiveness and on reduced overall costs and hospital stays, with similar results on overall survival rates comparing both models for autologous and allogeneic patients. We also found that the outpatient Hematopoietic Stem Cell Transplantation is a safe practice as well as less costly, it requires fewer days of hospital stay both for autologous and allogeneic transplantations. Under a situation of an increasing number of transplants, rising healthcare costs and shortages of hospital capacity, incorporating outpatient models could improve the quality of care for people requiring Hematopoietic Stem Cell Transplantation programs.
- 12 August 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (8) , e0254135
Open AccessHospital and outpatient models for Hematopoietic Stem Cell Transplantation: A systematic review of comparative studies for health outcomes, experience of care and costs
The number of Hematopoietic Stem Cell Transplantations has risen in the past 20 years. The practice of outpatient Hematopoietic Stem Cell Transplantation programs is increasing in an attempt to improve the quality of patient care and reduce the demand for hospital admission. A systematic review of 29 comparative studies between in-hospital and outpatient treatment of Hematopoietic Stem Cell Transplantation, with no restriction by outpatient regime was conducted. This study aims to analyse the current evidence on the effects of the outpatient model on patient-centred outcomes, comparing both in-hospital and outpatient models for autologous and allogeneic HSCT using the Triple Aim framework: health outcomes, costs and experience of care. We found evidence on improved health outcomes and quality of life, on enhanced safety and effectiveness and on reduced overall costs and hospital stays, with similar results on overall survival rates comparing both models for autologous and allogeneic patients. We also found that the outpatient Hematopoietic Stem Cell Transplantation is a safe practice as well as less costly, it requires fewer days of hospital stay both for autologous and allogeneic transplantations. Under a situation of an increasing number of transplants, rising healthcare costs and shortages of hospital capacity, incorporating outpatient models could improve the quality of care for people requiring Hematopoietic Stem Cell Transplantation programs.
- Open Access
- 28 April 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (5) , 509
Factors Influencing Healthcare Experience of Patients with Self-Declared Diabetes: A Cross-Sectional Population-Based Study in the Basque Country
Background: Diabetes affects more than 400 million people around the world. Few published studies incorporate questionnaires that comprehensively cover every aspect of a patient’s experience of healthcare. This study analyzes potential differences in the healthcare experience for patients with diabetes based on their sociodemographic, economic, and health-related characteristics from a comprehensive viewpoint in an integrated delivery system. Methods: We used data from the 2018 Basque Health Survey, which includes a questionnaire for the measurement of the experiences of patients with chronic problems. We present descriptive and regression analyses to explore differences by sociodemographic, economic, and health-related characteristics of patients’ experiences with different healthcare services. Results: Having diabetes plus other comorbidities significantly decreases the quality of the experience with all healthcare services and decreases the global healthcare experience score. When comorbidities are present, the elderly seem to report better experiences than younger patients. Some differences in experience can be explained by sociodemographic and economic factors. No differences exist between conditions co-occurring with diabetes. Conclusion: Patients with diabetes who also suffer from other conditions report worse experiences than individuals who suffer from diabetes only. No specific conditions explain the differences in care experience.
- 28 April 2021
- Published by MDPI AG in Healthcare
- Vol. 9 (5) , 509
Open AccessFactors Influencing Healthcare Experience of Patients with Self-Declared Diabetes: A Cross-Sectional Population-Based Study in the Basque Country
Background: Diabetes affects more than 400 million people around the world. Few published studies incorporate questionnaires that comprehensively cover every aspect of a patient’s experience of healthcare. This study analyzes potential differences in the healthcare experience for patients with diabetes based on their sociodemographic, economic, and health-related characteristics from a comprehensive viewpoint in an integrated delivery system. Methods: We used data from the 2018 Basque Health Survey, which includes a questionnaire for the measurement of the experiences of patients with chronic problems. We present descriptive and regression analyses to explore differences by sociodemographic, economic, and health-related characteristics of patients’ experiences with different healthcare services. Results: Having diabetes plus other comorbidities significantly decreases the quality of the experience with all healthcare services and decreases the global healthcare experience score. When comorbidities are present, the elderly seem to report better experiences than younger patients. Some differences in experience can be explained by sociodemographic and economic factors. No differences exist between conditions co-occurring with diabetes. Conclusion: Patients with diabetes who also suffer from other conditions report worse experiences than individuals who suffer from diabetes only. No specific conditions explain the differences in care experience.
- Open Access
- 1 January 2021
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 21 (S1) , 35
Development of MORE: an evaluative tool for measuring value-based integrated care
- 1 January 2021
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 21 (S1) , 35
Open AccessDevelopment of MORE: an evaluative tool for measuring value-based integrated care
- Open Access
- 12 May 2020
- Published by Hindawi Limited in Parkinson's Disease
- Vol. 2020, 1-6
Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies
Parkinsons disease is one of the main reasons for neurological consultation in Spain. Due to the nature of the disease, it impacts patients, families, and caregivers. Parkinsons disease is a degenerative disease with no cure, although second-line therapies have recently improved the quality of life of patients in advanced stages. The aim of this study was to analyse the costs of the following therapies: deep brain stimulation (DBS), continuous duodenal levodopa/carbidopa infusion (CDLCI), and continuous subcutaneous apomorphine infusion (CSAI). The methodology used was based on real-world data obtained from an integrated healthcare organization in the Basque Country from 2016 to 2018. This bottom-up retrospective approach only took into account the healthcare perspective. The results revealed the annual cost over 3 years and the projected cost for an additional 2 years. The total costs for 5 years of treatment were as follows: 53,217 for DBS, 208,163 for CDLCI, and 170,591 for CSAI. These costs are in line with those found in the available literature on the subject. Additionally, the analysis provided details of the different costs incurred during intervention with the therapies and compared the costs to those reported in other studies.
- 12 May 2020
- Published by Hindawi Limited in Parkinson's Disease
- Vol. 2020, 1-6
Open AccessDirect Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies
Parkinsons disease is one of the main reasons for neurological consultation in Spain. Due to the nature of the disease, it impacts patients, families, and caregivers. Parkinsons disease is a degenerative disease with no cure, although second-line therapies have recently improved the quality of life of patients in advanced stages. The aim of this study was to analyse the costs of the following therapies: deep brain stimulation (DBS), continuous duodenal levodopa/carbidopa infusion (CDLCI), and continuous subcutaneous apomorphine infusion (CSAI). The methodology used was based on real-world data obtained from an integrated healthcare organization in the Basque Country from 2016 to 2018. This bottom-up retrospective approach only took into account the healthcare perspective. The results revealed the annual cost over 3 years and the projected cost for an additional 2 years. The total costs for 5 years of treatment were as follows: 53,217 for DBS, 208,163 for CDLCI, and 170,591 for CSAI. These costs are in line with those found in the available literature on the subject. Additionally, the analysis provided details of the different costs incurred during intervention with the therapies and compared the costs to those reported in other studies.
- Open Access
- 6 June 2019
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 18 (1) , 82
Solidarity against healthcare access restrictions on undocumented immigrants in Spain: the REDER case study
In the context of public expenditure reduction and cuts, in 2012, the Spanish government approved the RDL 16/2012, which significantly affected the core values of the national health system. The measure particularly affected undocumented immigrants over 18 years of age, excluding them from accessing the full range of healthcare services in Spain, except for emergency care. In 2014, Red de Denuncia y Resistencia al RDL 16/2012 (REDER) was created as a public awareness and resistance network to defend universal access to healthcare and to stop its infringement. This study aims to analyse the social impact of REDER as a solidarity movement in response to the exclusion of undocumented immigrants from their universal right to health. Qualitative research methodologies were used for the research. Data were collected between November 2017 and December 2017, using eight semi-structured interviews with key informants from the main REDER stakeholders. Additionally, key publications, documents, and presentations of researchers and experts in the field were analysed. For data analysis, a framework extracted from the literature on exclusionary and transformative dimensions of solidarity was used to identify barriers and drivers in REDER’s intervention. From its creation to the present, REDER has been able to achieve many of its objectives to defend the right to medical care of groups in irregular situations, contributing to the identification of 4,755 cases of discrimination in healthcare access and helping solve over 90% of these cases by delivering either healthcare assistance or administrative support. REDER has also played an important role in: stimulating social activation and empowering citizens to claim their fundamental rights, organising actions against restrictions on accessibility and creating synergies to restore universal healthcare coverage. REDER has been shown to be effective in leading the defence of universal healthcare rights, and some achievements in the years following 2012 could be directly attributed to the work done by the network, such as the elimination of legal requirements to obtain health cards or the reduction of the minimum time required to access healthcare. Despite context particularities, the initiatives and main actions of this network may be implemented in other settings that are facing similar limitations to healthcare access, in order to address injustices and promote solidarity.
- 6 June 2019
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 18 (1) , 82
Open AccessSolidarity against healthcare access restrictions on undocumented immigrants in Spain: the REDER case study
In the context of public expenditure reduction and cuts, in 2012, the Spanish government approved the RDL 16/2012, which significantly affected the core values of the national health system. The measure particularly affected undocumented immigrants over 18 years of age, excluding them from accessing the full range of healthcare services in Spain, except for emergency care. In 2014, Red de Denuncia y Resistencia al RDL 16/2012 (REDER) was created as a public awareness and resistance network to defend universal access to healthcare and to stop its infringement. This study aims to analyse the social impact of REDER as a solidarity movement in response to the exclusion of undocumented immigrants from their universal right to health. Qualitative research methodologies were used for the research. Data were collected between November 2017 and December 2017, using eight semi-structured interviews with key informants from the main REDER stakeholders. Additionally, key publications, documents, and presentations of researchers and experts in the field were analysed. For data analysis, a framework extracted from the literature on exclusionary and transformative dimensions of solidarity was used to identify barriers and drivers in REDER’s intervention. From its creation to the present, REDER has been able to achieve many of its objectives to defend the right to medical care of groups in irregular situations, contributing to the identification of 4,755 cases of discrimination in healthcare access and helping solve over 90% of these cases by delivering either healthcare assistance or administrative support. REDER has also played an important role in: stimulating social activation and empowering citizens to claim their fundamental rights, organising actions against restrictions on accessibility and creating synergies to restore universal healthcare coverage. REDER has been shown to be effective in leading the defence of universal healthcare rights, and some achievements in the years following 2012 could be directly attributed to the work done by the network, such as the elimination of legal requirements to obtain health cards or the reduction of the minimum time required to access healthcare. Despite context particularities, the initiatives and main actions of this network may be implemented in other settings that are facing similar limitations to healthcare access, in order to address injustices and promote solidarity.
- Open Access
- 22 October 2018
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 18 (s2)
Building a narrative for compassionate communities: the case of Getxo Zurekin
- 22 October 2018
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 18 (s2)
Open AccessBuilding a narrative for compassionate communities: the case of Getxo Zurekin